Human Reproductive Cloning Act 2001

Last updated

Human Reproductive Cloning Act
Act of Parliament
Royal Coat of Arms of the United Kingdom (variant 1, 1952-2022).svg
Long title An Act to prohibit the placing in a woman of a human embryo which has been created otherwise than by fertilisation.
Citation 2001 c. 23
Dates
Royal assent 4 December 2001
Repealed1 October 2009
Other legislation
Repealed by Human Fertilisation and Embryology Act 2008
Status: Repealed
Text of statute as originally enacted
Text of the Human Reproductive Cloning Act 2001 as in force today (including any amendments) within the United Kingdom, from legislation.gov.uk.

The Human Reproductive Cloning Act 2001 (c. 23) was an Act of the Parliament of the United Kingdom "to prohibit the placing in a woman of a human embryo which has been created otherwise than by fertilisation". The act received Royal Assent on 4 December 2001.

On 14 January 2001, the British government passed The Human Fertilisation and Embryology (Research Purposes) Regulations 2001 [1] to amend the Human Fertilisation and Embryology Act 1990 by extending allowable reasons for embryo research to permit research around stem cells and cell nuclear replacement, thus allowing therapeutic cloning. However, on 15 November 2001, a pro-life group won a High Court legal challenge, which struck down the regulation and effectively left all forms of cloning unregulated in the UK. Their hope was that Parliament would fill this gap by passing prohibitive legislation. [2] [3] Parliament was quick to pass the Human Reproductive Cloning Act 2001 in order to explicitly prohibit reproductive cloning. The remaining gap with regard to therapeutic cloning was closed when the appeals courts reversed the previous decision of the High Court. [4]

The act was repealed and replaced by the Human Fertilisation and Embryology Act 2008.

Related Research Articles

<span class="mw-page-title-main">Human cloning</span> Creation of a genetically identical copy of a human

Human cloning is the creation of a genetically identical copy of a human. The term is generally used to refer to artificial human cloning, which is the reproduction of human cells and tissue. It does not refer to the natural conception and delivery of identical twins. The possibilities of human cloning have raised controversies. These ethical concerns have prompted several nations to pass laws regarding human cloning.

<span class="mw-page-title-main">Somatic cell nuclear transfer</span> Method of creating a cloned embryo by replacing the egg nucleus with a body cell nucleus

In genetics and developmental biology, somatic cell nuclear transfer (SCNT) is a laboratory strategy for creating a viable embryo from a body cell and an egg cell. The technique consists of taking an denucleated oocyte and implanting a donor nucleus from a somatic (body) cell. It is used in both therapeutic and reproductive cloning. In 1996, Dolly the sheep became famous for being the first successful case of the reproductive cloning of a mammal. In January 2018, a team of scientists in Shanghai announced the successful cloning of two female crab-eating macaques from foetal nuclei.

S1909/A2840 is a bill that was passed by the New Jersey Legislature in December 2003, and signed into law by Governor James McGreevey on January 4, 2004, that permits human cloning for the purpose of developing and harvesting human stem cells. Specifically, it legalizes the process of cloning a human embryo, and implanting the clone into a womb, provided that the clone is then aborted and used for medical research. The legislation was sponsored by Senators Richard Codey (D-Essex) and Barbara Buono, and Assembly members Neil M. Cohen (D-Union), John F. McKeon, Mims Hackett (D-Essex), and Joan M. Quigley (D-Hudson). The enactment of this law will enable researchers to find cures for debilitating and deadly diseases.

<span class="mw-page-title-main">Human Fertilisation and Embryology Authority</span>

The Human Fertilisation and Embryology Authority (HFEA) is an executive non-departmental public body of the Department of Health and Social Care in the United Kingdom. It is a statutory body that regulates and inspects all clinics in the United Kingdom providing in vitro fertilisation (IVF), artificial insemination and the storage of human eggs, sperm or embryos. It also regulates human embryo research.

The Dickey–Wicker Amendment is the name of an appropriation bill rider attached to a bill passed by United States Congress in 1995, and signed by former President Bill Clinton, which prohibits the United States Department of Health and Human Services (HHS) from using appropriated funds for the creation of human embryos for research purposes or for research in which human embryos are destroyed. HHS funding includes the funding for the National Institutes of Health (NIH). It is named after Jay Dickey and Roger Wicker, two Republican Representatives. Technically, the Dickey Amendment is a rider to other legislation, which amends the original legislation. The rider receives its name from the name of the Congressman that originally introduced the amendment, Representative Dickey. The Dickey amendment language has been added to each of the Labor, HHS, and Education appropriations acts for fiscal years 1997 through 2009. The original rider can be found in Section 128 of P.L. 104–99.

A cytoplasmic hybrid is a eukaryotic cell line produced by the fusion of a whole cell with a cytoplast. Cytoplasts are enucleated cells. This enucleation can be effected by simultaneous application of centrifugal force and treatment of the cell with an agent that disrupts the cytoskeleton. A special case of cybrid formation involves the use of rho-zero cells as the whole cell partner in the fusion. Rho-zero cells are cells which have been depleted of their own mitochondrial DNA by prolonged incubation with ethidium bromide, a chemical which inhibits mitochondrial DNA replication. The rho-zero cells do retain mitochondria and can grow in rich culture medium with certain supplements. They do retain their own nuclear genome. A cybrid is then a hybrid cell which mixes the nuclear genes from one cell with the mitochondrial genes from another cell. Using this powerful tool, it makes it possible to dissociate contribution from the mitochondrial genes vs that of the nuclear genes.

<span class="mw-page-title-main">Designer baby</span> Genetically modified human embryo

A designer baby is a baby whose genetic makeup has been selected or altered, often to exclude a particular gene or to remove genes associated with disease. This process usually involves analysing a wide range of human embryos to identify genes associated with particular diseases and characteristics, and selecting embryos that have the desired genetic makeup; a process known as preimplantation genetic diagnosis. Screening for single genes is commonly practiced, and polygenic screening is offered by a few companies. Other methods by which a baby's genetic information can be altered involve directly editing the genome before birth, which is not routinely performed and only one instance of this is known to have occurred as of 2019, where Chinese twins Lulu and Nana were edited as embryos, causing widespread criticism.

Christians take multiple positions in the debate on the morality of human cloning. Since Dolly the sheep was successfully cloned on 5 July 1996, and the possibility of cloning humans became a reality, Christian leaders have been pressed to take an ethical stance on its morality. While many Christians tend to disagree with the practice, such as Roman Catholics and a majority of fundamentalist pastors, including Southern Baptists, the views taken by various other Christian denominations are diverse and often conflicting. It is hard to pinpoint any one, definite stance of the Christian religion, since there are so many Christian denominations and so few official statements from each of them concerning the morality of human cloning.

Stem cell research policy varies significantly throughout the world. There are overlapping jurisdictions of international organizations, nations, and states or provinces. Some government policies determine what is allowed versus prohibited, whereas others outline what research can be publicly financed. Of course, all practices not prohibited are implicitly permitted. Some organizations have issued recommended guidelines for how stem cell research is to be conducted.

Evans v. the United Kingdom was a key case at the European Court of Human Rights. The case outcome could have had a major impact on fertility law, not only within the United Kingdom but also the other Council of Europe countries.

<span class="mw-page-title-main">Human Fertilisation and Embryology Act 1990</span> United Kingdom legislation

The Human Fertilisation and Embryology Act 1990 is an Act of the Parliament of the United Kingdom. It created the Human Fertilisation and Embryology Authority which is in charge of human embryo research, along with monitoring and licensing fertility clinics in the United Kingdom.

Posthumous sperm retrieval (PSR) is a procedure in which spermatozoa are collected from the testes of a human corpse after brain death. There has been significant debate over the ethics and legality of the procedure, and on the legal rights of the child and surviving parent if the gametes are used for impregnation.

Stem cell laws are the law rules, and policy governance concerning the sources, research, and uses in treatment of stem cells in humans. These laws have been the source of much controversy and vary significantly by country. In the European Union, stem cell research using the human embryo is permitted in Sweden, Spain, Finland, Belgium, Greece, Britain, Denmark and the Netherlands; however, it is illegal in Germany, Austria, Ireland, Italy, and Portugal. The issue has similarly divided the United States, with several states enforcing a complete ban and others giving support. Elsewhere, Japan, India, Iran, Israel, South Korea, China, and Australia are supportive. However, New Zealand, most of Africa, and most of South America are restrictive.

Stem cell laws and policy in the United States have had a complicated legal and political history.

Religious response to assisted reproductive technology deals with the new challenges for traditional social and religious communities raised by modern assisted reproductive technology. Because many religious communities have strong opinions and religious legislation regarding marriage, sex and reproduction, modern fertility technology has forced religions to respond.

<span class="mw-page-title-main">Human Fertilisation and Embryology Act 2008</span> United Kingdom legislation

The Human Fertilisation and Embryology Act 2008 is an Act of the Parliament of the United Kingdom. The Act constitutes a major review and update of the Human Fertilisation and Embryology Act 1990.

Mitochondrial replacement therapy (MRT), sometimes called mitochondrial donation, is the replacement of mitochondria in one or more cells to prevent or ameliorate disease. MRT originated as a special form of in vitro fertilisation in which some or all of the future baby's mitochondrial DNA (mtDNA) comes from a third party. This technique is used in cases when mothers carry genes for mitochondrial diseases. The therapy is approved for use in the United Kingdom. A second application is to use autologous mitochondria to replace mitochondria in damaged tissue to restore the tissue to a functional state. This has been used in clinical research in the United States to treat cardiac-compromised newborns.

<i>Assisted Human Reproduction Act</i>

The Assisted Human Reproduction Act is law enacted by the Parliament of Canada. Its purpose is to regulate assisted human reproduction (AHR) and related research. It is one of the most comprehensive pieces of legislation in the world concerning reproductive technologies and related research. It was introduced and passed in 2004 and was fully in force by 2007.

<span class="mw-page-title-main">Surrogacy Arrangements Act 1985</span> United Kingdom legislation

The Surrogacy Arrangements Act 1985 is an Act of the Parliament of the United Kingdom that prohibits commercial surrogacy arrangements. It received Royal Assent on 16 July 1985.

<span class="mw-page-title-main">Surrogacy laws by country</span>

The legal aspects of surrogacy in any particular jurisdiction tend to hinge on a few central questions:

References

  1. Statutory Instrument 2001 No. 188 Human Fertilisation and Embryology (Research Purposes) Regulations
  2. SD Pattinson (2006), Medical Law and Ethics, Sweet & Maxwell, ISBN   978-0-421-88950-7
  3. "Campaigners win cloning challenge". BBC News Online . 15 November 2001.
  4. "Lords uphold cloning law". BBC News Online . 13 March 2003.